Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

87.50 -1.58 (-1.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,556,380
Open 88.40
Bid (Size) 87.61 (1)
Ask (Size) 89.00 (1)
Prev. Close 89.08
Today's Range 87.14 - 89.00
52wk Range 78.94 - 139.55
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
The beauty of healthcare stocks is that they tend to do well in most economic conditions because you can’t live without them. 
Via InvestorPlace
DexCom Unusual Options Activity For September 22
Via Benzinga

Performance

YTD
-23.73%
-23.73%
1 Month
-16.17%
-16.17%
3 Month
-30.97%
-30.97%
6 Month
-23.31%
-23.31%
1 Year
+8.08%
+8.08%

More News

Read More
2 Healthcare Stocks That Could Make You Richer
Via The Motley Fool
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Via The Motley Fool
DexCom Unusual Options Activity
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $6,500 Today
Via Benzinga
Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program
From Dexcom, Inc.
Via Business Wire
3 Stock-Split Stocks Billionaire Investors Can't Stop Buying
Via The Motley Fool
Why DexCom Stock Dove by 5% Today
Via The Motley Fool
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Via Benzinga
How Is The Market Feeling About DexCom?
Via Benzinga
Expert Ratings for DexCom
Via Benzinga
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
Via The Motley Fool
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar
Via Investor's Business Daily
AeroVironment, Daktronics, GitLab And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
Via The Motley Fool
$1000 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
Via MarketBeat
1 Stock-Split Stock to Buy Hand Over Fist in September and 1 to Avoid Like the Plague
Via The Motley Fool
2 Stock-Split AI Growth Stocks to Buy Before They Soar 53% and 135%, According to Wall Street
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
Dexcom Appoints Rimma Driscoll to Board of Directors
From DexCom, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.